Pro Medicus (ASX:PME) Shares Up 2.5%

Pro Medicus Limited (ASX:PME)’s stock price shot up 2.5% on Monday . The stock traded as high as A$32.14 ($22.79) and last traded at A$31.66 ($22.45), 274,374 shares changed hands during mid-day trading. The stock had previously closed at A$30.90 ($21.91).

The company’s fifty day moving average is A$29.80 and its two-hundred day moving average is A$24.32. The stock has a market cap of $3.29 billion and a price-to-earnings ratio of 173.01.

The company also recently announced a Final dividend, which was paid on Friday, October 4th. Investors of record on Friday, October 4th were issued a $0.045 dividend. This is a boost from Pro Medicus’s previous Final dividend of $0.03. The ex-dividend date of this dividend was Thursday, September 12th. This represents a yield of 0.15%. Pro Medicus’s dividend payout ratio (DPR) is 49.18%.

In related news, insider Sam Hupert sold 1,000,000 shares of the firm’s stock in a transaction that occurred on Friday, September 6th. The shares were sold at an average price of A$36.10 ($25.60), for a total value of A$36,100,000.00 ($25,602,836.88).

Pro Medicus Company Profile (ASX:PME)

Pro Medicus Limited provides radiology information systems (RIS), picture archiving and communication systems (PACS), and advanced visualization solutions worldwide. It offers medical software for practice management; integration products; Promedicus.net secure email; healthcare software that provides radiologist and clinicians with advanced visualization capability for viewing 2-D, 3-D, and 4-D medical images; and PACS/Digital imaging software.

Recommended Story: What are the Benefits of Index Funds?

Receive News & Ratings for Pro Medicus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pro Medicus and related companies with MarketBeat.com's FREE daily email newsletter.